PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1731135
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1731135
Mobile Medical Imaging Services Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)
The global mobile medical imaging services market was valued at USD 16.1 billion in 2024 and is projected to reach USD 24.2 billion by 2032, advancing at a CAGR of 5.3% during 2025-2032. This growth is driven by the increasing demand for accessible and cost-effective diagnostic services, particularly in underserved and remote areas. Mobile imaging services-including X-rays, ultrasounds, MRIs, and CT scans-offer the flexibility of bringing diagnostic equipment directly to patients, reducing the need for hospital visits and enhancing patient convenience.
Technological advancements, such as the integration of artificial intelligence (AI) in imaging systems, are further propelling market growth. AI-enhanced mobile imaging devices improve diagnostic accuracy and efficiency, enabling quicker decision-making and better patient outcomes. Additionally, the rising prevalence of chronic diseases and the growing geriatric population are contributing to the increased adoption of mobile medical imaging services.
Key Insights
The market is segmented by type into X-ray, CT, ultrasound, and MRI, with mobile X-ray services accounting for the largest revenue share due to their widespread use and cost-effectiveness.
Hospitals and clinics constitute the largest end-user category, leveraging mobile imaging services to enhance patient care and optimize resource utilization.
North America holds the largest market share, attributed to advanced healthcare infrastructure and high adoption rates of mobile imaging technologies.
The Asia-Pacific region is expected to witness the fastest growth, driven by increasing healthcare investments and the need for improved diagnostic services in rural areas.
Integration of AI in mobile imaging systems is enhancing diagnostic capabilities, with companies developing AI-based solutions to assist healthcare professionals.
Government initiatives aimed at improving healthcare accessibility are supporting the expansion of mobile medical imaging services, particularly in regions with limited healthcare infrastructure.
The increasing prevalence of chronic diseases, such as cancer and cardiovascular conditions, is driving the demand for timely and accurate diagnostic imaging.
Advancements in portable imaging technologies are enabling the development of compact and efficient devices, facilitating easier deployment in various healthcare settings.
Collaborations between healthcare providers and mobile imaging service companies are enhancing service delivery and expanding the reach of diagnostic services.
The ongoing digitization of healthcare systems is streamlining data management and improving the integration of mobile imaging services into existing healthcare workflows.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market Size Breakdown, by Type
- 1.4.2. Market Size Breakdown, by Patient Type
- 1.4.3. Market Size Breakdown, by End User
- 1.4.4. Market Size Breakdown, by Region
- 1.4.5. Market Size Breakdown, by Country
- 1.5. Market Data Reporting Unit
- 1.5.1. Revenue
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence Database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Industry Background
- 5.2. Market Dynamics
- 5.2.1. Trends
- 5.2.2. Drivers
- 5.2.3. Restraints/Challenges
- 5.2.4. Emerging Economies and Key Opportunities
- 5.2.5. Impact Analysis of Drivers/Restraints
- 5.3. Impact of COVID-19
- 5.4. Sociopolitical Impact
- 5.5. Porter's Five Forces Analysis
- 5.5.1. Bargaining Power of Buyers
- 5.5.2. Bargaining Power of Suppliers
- 5.5.3. Threat of New Entrants
- 5.5.4. Intensity of Rivalry
- 5.5.5. Threat of Substitutes
- 5.6. Market Entry Strategies
Chapter 6. Competitive Landscape
- 6.1. List of Market Players and their Offerings
- 6.2. Market Share of Key Players (2024)
- 6.2.1. Global
- 6.2.2. North America
- 6.2.3. Europe
- 6.2.4. Asia-Pacific
- 6.2.5. Latin America
- 6.2.6. Middle East and Africa
- 6.3. Competitive Benchmarking of Key Players
- 6.4. Product Benchmarking of Key Players
- 6.5. Recent Strategic Developments by Key Players
- 6.6. Company Leadership Matrix
Chapter 7. Global Market
- 7.1. Overview
- 7.2. Market Revenue, by Type (2019-2032)
- 7.3. Market Revenue, by Patient Type (2019-2032)
- 7.4. Market Revenue, by End User (2019-2032)
- 7.5. Market Revenue, by Region (2019-2032)
Chapter 8. North America Market
- 8.1. Overview
- 8.2. Market Revenue, by Type (2019-2032)
- 8.3. Market Revenue, by Patient Type (2019-2032)
- 8.4. Market Revenue, by End User (2019-2032)
- 8.5. Market Revenue, by Country (2019-2032)
Chapter 9. Europe Market
- 9.1. Overview
- 9.2. Market Revenue, by Type (2019-2032)
- 9.3. Market Revenue, by Patient Type (2019-2032)
- 9.4. Market Revenue, by End User (2019-2032)
- 9.5. Market Revenue, by Country (2019-2032)
Chapter 10. Asia-Pacific Market
- 10.1. Overview
- 10.2. Market Revenue, by Type (2019-2032)
- 10.3. Market Revenue, by Patient Type (2019-2032)
- 10.4. Market Revenue, by End User (2019-2032)
- 10.5. Market Revenue, by Country (2019-2032)
Chapter 11. Latin America Market
- 11.1. Overview
- 11.2. Market Revenue, by Type (2019-2032)
- 11.3. Market Revenue, by Patient Type (2019-2032)
- 11.4. Market Revenue, by End User (2019-2032)
- 11.5. Market Revenue, by Country (2019-2032)
Chapter 12. Middle East and Africa Market
- 12.1. Overview
- 12.2. Market Revenue, by Type (2019-2032)
- 12.3. Market Revenue, by Patient Type (2019-2032)
- 12.4. Market Revenue, by End User (2019-2032)
- 12.5. Market Revenue, by Country (2019-2032)
Chapter 13. U.S. Market
- 13.1. Overview
- 13.2. Market Size and Forecast
- 13.2.1. Market Revenue, by Type (2019-2032)
- 13.2.2. Market Revenue, by Patient Type (2019-2032)
- 13.2.3. Market Revenue, by End User (2019-2032)
Chapter 14. Canada Market
- 14.1. Overview
- 14.2. Market Size and Forecast
- 14.2.1. Market Revenue, by Type (2019-2032)
- 14.2.2. Market Revenue, by Patient Type (2019-2032)
- 14.2.3. Market Revenue, by End User (2019-2032)
Chapter 15. Germany Market
- 15.1. Overview
- 15.2. Market Size and Forecast
- 15.2.1. Market Revenue, by Type (2019-2032)
- 15.2.2. Market Revenue, by Patient Type (2019-2032)
- 15.2.3. Market Revenue, by End User (2019-2032)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Size and Forecast
- 16.2.1. Market Revenue, by Type (2019-2032)
- 16.2.2. Market Revenue, by Patient Type (2019-2032)
- 16.2.3. Market Revenue, by End User (2019-2032)
Chapter 17. France Market
- 17.1. Overview
- 17.2. Market Size and Forecast
- 17.2.1. Market Revenue, by Type (2019-2032)
- 17.2.2. Market Revenue, by Patient Type (2019-2032)
- 17.2.3. Market Revenue, by End User (2019-2032)
Chapter 18. Italy Market
- 18.1. Overview
- 18.2. Market Size and Forecast
- 18.2.1. Market Revenue, by Type (2019-2032)
- 18.2.2. Market Revenue, by Patient Type (2019-2032)
- 18.2.3. Market Revenue, by End User (2019-2032)
Chapter 19. Spain Market
- 19.1. Overview
- 19.2. Market Size and Forecast
- 19.2.1. Market Revenue, by Type (2019-2032)
- 19.2.2. Market Revenue, by Patient Type (2019-2032)
- 19.2.3. Market Revenue, by End User (2019-2032)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Size and Forecast
- 20.2.1. Market Revenue, by Type (2019-2032)
- 20.2.2. Market Revenue, by Patient Type (2019-2032)
- 20.2.3. Market Revenue, by End User (2019-2032)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Size and Forecast
- 21.2.1. Market Revenue, by Type (2019-2032)
- 21.2.2. Market Revenue, by Patient Type (2019-2032)
- 21.2.3. Market Revenue, by End User (2019-2032)
Chapter 22. Japan Market
- 22.1. Overview
- 22.2. Market Size and Forecast
- 22.2.1. Market Revenue, by Type (2019-2032)
- 22.2.2. Market Revenue, by Patient Type (2019-2032)
- 22.2.3. Market Revenue, by End User (2019-2032)
Chapter 23. Australia Market
- 23.1. Overview
- 23.2. Market Size and Forecast
- 23.2.1. Market Revenue, by Type (2019-2032)
- 23.2.2. Market Revenue, by Patient Type (2019-2032)
- 23.2.3. Market Revenue, by End User (2019-2032)
Chapter 24. South Korea Market
- 24.1. Overview
- 24.2. Market Size and Forecast
- 24.2.1. Market Revenue, by Type (2019-2032)
- 24.2.2. Market Revenue, by Patient Type (2019-2032)
- 24.2.3. Market Revenue, by End User (2019-2032)
Chapter 25. Brazil Market
- 25.1. Overview
- 25.2. Market Size and Forecast
- 25.2.1. Market Revenue, by Type (2019-2032)
- 25.2.2. Market Revenue, by Patient Type (2019-2032)
- 25.2.3. Market Revenue, by End User (2019-2032)
Chapter 26. Mexico Market
- 26.1. Overview
- 26.2. Market Size and Forecast
- 26.2.1. Market Revenue, by Type (2019-2032)
- 26.2.2. Market Revenue, by Patient Type (2019-2032)
- 26.2.3. Market Revenue, by End User (2019-2032)
Chapter 27. Saudi Arabia Market
- 27.1. Overview
- 27.2. Market Size and Forecast
- 27.2.1. Market Revenue, by Type (2019-2032)
- 27.2.2. Market Revenue, by Patient Type (2019-2032)
- 27.2.3. Market Revenue, by End User (2019-2032)
Chapter 28. South Africa Market
- 28.1. Overview
- 28.2. Market Size and Forecast
- 28.2.1. Market Revenue, by Type (2019-2032)
- 28.2.2. Market Revenue, by Patient Type (2019-2032)
- 28.2.3. Market Revenue, by End User (2019-2032)
Chapter 29. U.A.E. Market
- 29.1. Overview
- 29.2. Market Size and Forecast
- 29.2.1. Market Revenue, by Type (2019-2032)
- 29.2.2. Market Revenue, by Patient Type (2019-2032)
- 29.2.3. Market Revenue, by End User (2019-2032)
Chapter 30. Company Profiles
Chapter 31. Appendix
- 31.1. Sources and References
- 31.2. Related Reports
